ArticleThe oncologist2021

Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapies.

Andrew J Wiele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.